Assets of COSCIENS Biopharma Inc. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD and CAD
Summary
COSCIENS Biopharma Inc. quarterly Assets in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • COSCIENS Biopharma Inc. Assets for the quarter ending 31 Dec 2024 was $35,070,000, a 48% increase year-over-year.
COSCIENS Biopharma Inc. quarterly Assets in CAD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • COSCIENS Biopharma Inc. Assets for the quarter ending 31 Dec 2023 was CA$31,446,000, a 17% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)
Assets, Quarterly (CAD)
Assets, YoY Quarterly Change (%)

COSCIENS Biopharma Inc. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $35,070,000 +$11,325,000 +48% 31 Dec 2024 20-F 09 Apr 2025 2024 FY
Q3 2024 $43,769,000 +$1,283,000 +3% 30 Sep 2024 6-K 12 Nov 2024 2024 Q3
Q2 2024 $50,045,000 +$3,562,000 +7.7% 30 Jun 2024 6-K 13 Aug 2024 2024 Q2
Q1 2024 $31,792,000 -$19,490,000 -38% 31 Mar 2024 6-K 16 May 2024 2024 Q1
Q4 2023 $23,745,000 -$4,095,000 -15% 31 Dec 2023 20-F 09 Apr 2025 2024 FY
Q3 2023 $42,486,000 -$24,120,000 -36% 30 Sep 2023 6-K 09 Nov 2023 2023 Q3
Q2 2023 $46,483,000 -$25,342,000 -35% 30 Jun 2023 6-K 09 Aug 2023 2023 Q2
Q1 2023 $51,282,000 -$25,062,000 -33% 31 Mar 2023 6-K 09 May 2023 2023 Q1
Q4 2022 $27,840,000 -$52,262,000 -65% 31 Dec 2022 20-F 09 Apr 2025 2024 FY
Q3 2022 $66,606,000 -$15,436,000 -19% 30 Sep 2022 6-K 03 Nov 2022 2022 Q3
Q2 2022 $71,825,000 -$12,527,000 -15% 30 Jun 2022 6-K/A 04 Aug 2022 2022 Q2
Q1 2022 $76,344,000 -$10,670,000 -12% 31 Mar 2022 6-K 11 May 2022 2022 Q1
Q4 2021 $80,102,000 +$43,097,000 +116% 31 Dec 2021 20-F/A 15 Feb 2024 2022 FY
Q3 2021 $82,042,000 +$49,771,000 +154% 30 Sep 2021 6-K 04 Nov 2021 2021 Q3
Q2 2021 $84,352,000 +$66,683,000 +377% 30 Jun 2021 6-K 05 Aug 2021 2021 Q2
Q1 2021 $87,014,000 +$67,373,000 +343% 31 Mar 2021 6-K 05 May 2021 2021 Q1
Q4 2020 $37,005,000 +$17,024,000 +85% 31 Dec 2020 20-F 29 Mar 2022 2021 FY
Q3 2020 $32,271,000 +$10,769,000 +50% 30 Sep 2020 6-K 05 Nov 2020 2020 Q3
Q2 2020 $17,669,000 -$3,082,000 -15% 30 Jun 2020 6-K 06 Aug 2020 2020 Q2
Q1 2020 $19,641,000 31 Mar 2020 6-K/A 11 May 2020 2020 Q1
Q4 2019 $19,981,000 -$5,030,000 -20% 31 Dec 2019 40-F/A 29 Mar 2021 2020 FY
Q3 2019 $21,502,000 30 Sep 2019 6-K 07 Nov 2019 2019 Q3
Q2 2019 $20,751,000 30 Jun 2019 6-K 13 Aug 2019 2019 Q2
Q4 2018 $25,011,000 +$2,816,000 +13% 31 Dec 2018 20-F 31 Mar 2020 2019 FY
Q4 2017 $22,195,000 -$9,464,000 -30% 31 Dec 2017 20-F 01 Apr 2019 2018 FY
Q4 2016 $31,659,000 31 Dec 2016 20-F 28 Mar 2018 2017 FY

COSCIENS Biopharma Inc. Quarterly Assets (CAD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 CA$31,446,000 -CA$6,288,000 -17% 31 Dec 2023 20-F 09 Apr 2025 2024 FY
Q4 2022 CA$37,734,000 31 Dec 2022 20-F 09 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.